Covid-19 Dose To Cost 300 Shillings Once Ready

By Soko Directory Team / Published August 18, 2020 | 11:07 am



vaccine-vaccines

By Getrude Matayo

According to the world’s biggest vaccines manufacturer, Serum Institute of India, a leading Covid-19 vaccine candidate will cost Kenya 300 shillings per dose.

Serum Institute of India has been contracted to supply developing countries with the University of Oxford-AstraZeneca vaccine as soon as it is prequalified this year or in 2021.

SII has been contracted by Gavi, the Geneva-based alliance that is leading a global initiative to secure Covid-19 vaccines for developing countries.

Gavi has already listed Kenya among the 92 countries that will benefit from its ongoing negotiations with different manufacturers.  According to the biotechnology company, Novavax will soon begin the second phase of human testing for its Covid-19 vaccine.

According to a statement released by Novavax on August 7th, Phase 2b clinical trial will include a group of 2,665 healthy adults in South Africa as well as a group of 240 adults with HIV who are considered medically stable but whose immune responses may differ from individuals without HIV.

The World Health Organization says more than 160 candidate vaccines are in progress around the world, with 29 in human trials. Dr. Seth Berkley, CEO of Gavi, in a statement, said that too many times they have seen the most vulnerable countries left at the back of the queue when it comes to new treatments, new diagnostics, and new vaccines.

He added that this new collaboration is an important step in their efforts to prevent this from happening, helping to ensure they have the additional manufacturing capacity to begin producing doses for every country, not just the wealthy few. He said that they now need other vaccine manufacturers to step up and follow SII’s lead.

READ: Car And General (K) Kicks Off The Week As Top Gainer Of The Day

SII will manufacture and deliver up to 100 million doses around the world under the Gavi Advance Market Commitment for the Covid-19 Vaccines (Covax) initiative, as early as the first half of 2021.

Science Magazine reported that HIV advocacy group have pushed for people with HIV to be included in clinical trials for Covid-19 vaccines, as companies like Moderna and Pfizer initially said they would exclude volunteers with the infection

SII CEO Adar Poonawalla, in a statement, said that to ensure maximum immunization coverage and contain the pandemic, it is important to make sure that the most remote and poorest countries of the world have access to affordable cure and preventive measures

READ: Family Bank Registers 63.3% Increase In Profits In 6 Months





About Soko Directory Team

Soko Directory is a Financial and Markets digital portal that tracks brands, listed firms on the NSE, SMEs and trend setters in the markets eco-system.Find us on Facebook: facebook.com/SokoDirectory and on Twitter: twitter.com/SokoDirectory

View other posts by Soko Directory Team


More Articles From This Author






Trending Stories










Other Related Articles










SOKO DIRECTORY & FINANCIAL GUIDE



ARCHIVES

2021
  • January 2021 (182)
  • February 2021 (227)
  • March 2021 (325)
  • April 2021 (261)
  • May 2021 (131)
  • 2020
  • January 2020 (272)
  • February 2020 (310)
  • March 2020 (390)
  • April 2020 (321)
  • May 2020 (335)
  • June 2020 (327)
  • July 2020 (334)
  • August 2020 (276)
  • September 2020 (214)
  • October 2020 (233)
  • November 2020 (242)
  • December 2020 (187)
  • 2019
  • January 2019 (253)
  • February 2019 (216)
  • March 2019 (285)
  • April 2019 (254)
  • May 2019 (272)
  • June 2019 (251)
  • July 2019 (338)
  • August 2019 (293)
  • September 2019 (306)
  • October 2019 (313)
  • November 2019 (362)
  • December 2019 (319)
  • 2018
  • January 2018 (291)
  • February 2018 (213)
  • March 2018 (278)
  • April 2018 (225)
  • May 2018 (237)
  • June 2018 (178)
  • July 2018 (256)
  • August 2018 (249)
  • September 2018 (256)
  • October 2018 (287)
  • November 2018 (284)
  • December 2018 (186)
  • 2017
  • January 2017 (183)
  • February 2017 (194)
  • March 2017 (207)
  • April 2017 (104)
  • May 2017 (169)
  • June 2017 (205)
  • July 2017 (190)
  • August 2017 (195)
  • September 2017 (186)
  • October 2017 (235)
  • November 2017 (253)
  • December 2017 (266)
  • 2016
  • January 2016 (165)
  • February 2016 (165)
  • March 2016 (190)
  • April 2016 (143)
  • May 2016 (245)
  • June 2016 (182)
  • July 2016 (271)
  • August 2016 (248)
  • September 2016 (234)
  • October 2016 (191)
  • November 2016 (243)
  • December 2016 (153)
  • 2015
  • January 2015 (1)
  • February 2015 (4)
  • March 2015 (166)
  • April 2015 (108)
  • May 2015 (116)
  • June 2015 (120)
  • July 2015 (148)
  • August 2015 (157)
  • September 2015 (188)
  • October 2015 (169)
  • November 2015 (173)
  • December 2015 (207)
  • 2014
  • March 2014 (2)
  • 2013
  • March 2013 (10)
  • June 2013 (1)
  • 2012
  • March 2012 (7)
  • April 2012 (15)
  • May 2012 (1)
  • July 2012 (1)
  • August 2012 (4)
  • October 2012 (2)
  • November 2012 (2)
  • December 2012 (1)
  • 2011
    2010
    2009
    2008
    2007
    2006
    2005
    2004
    2003
    2002
    2001
    2000
    1999
    1998
    1997
    1996
    1995
    1994
    1993
    1992
    1991
    1990
    1989
    1988
    1987
    1986
    1985
    1984
    1983
    1982
    1981
    1980
    1979
    1978
    1977
    1976
    1975
    1974
    1973
    1972
    1971
    1970
    1969
    1968
    1967
    1966
    1965
    1964
    1963
    1962
    1961
    1960
    1959
    1958
    1957
    1956
    1955
    1954
    1953
    1952
    1951
    1950